agonistas de la glp 1 GLP-1. Uso inapropiado ArGLP-1: implicaciones clínicas, éticas y de farmacovigilancia Seguramente has escuchado hablar de

"I have definitely been asked by many athletes, both amateur and professional, about GLP-1s," said Dr

Introduction According to the reports of the International Diabetes Federation, there were 537 million patients with diabetes worldwide in 2021, and the prevalence of diabetes was estimated at 10.5% ( With the extensive use of GLP-1 RAs, adverse drug reaction (ADR) reports are increasing gradually, which has attracted the attention of clinicians and drug administrations

Regarding tolerability, evidence indicates that GLP-1RAs are safe for non-diabetic obese patients

Dermatologists can provide personalized recommendations and ensure the product is suitable for your unique skin needs

[1] However, consistency in timing may help with adherence and potentially minimize side effects